Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
28
-
Total 13F shares, excl. options
-
21,198,794
-
Shares change
-
+21,018,388
-
Total reported value, excl. options
-
$97,089,813
-
Value change
-
+$96,755,407
-
Number of buys
-
25
-
Number of sells
-
-5
-
Price
-
$4.58
Significant Holders of Sonnet BioTherapeutics Holdings, Inc. - COM NEW (SONN) as of Q3 2025
31 filings reported holding SONN - Sonnet BioTherapeutics Holdings, Inc. - COM NEW as of Q3 2025.
Sonnet BioTherapeutics Holdings, Inc. - COM NEW (SONN) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21,198,794 shares
.
Largest 10 shareholders include Pantera Capital Partners LP (20,427,696 shares), Ikarian Capital, LLC (150,000 shares), VANGUARD GROUP INC (96,382 shares), HRT FINANCIAL LP (74,265 shares), GEODE CAPITAL MANAGEMENT, LLC (61,840 shares), BOOTHBAY FUND MANAGEMENT, LLC (56,339 shares), GOLDMAN SACHS GROUP INC (55,134 shares), BIT Capital GmbH (48,358 shares), CITADEL ADVISORS LLC (46,082 shares), and Virtu Financial LLC (26,266 shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.